The FDA’s next move, $549 headphones and overly optimistic?

The FDA’s next move, $549 headphones and overly optimistic?

  • Höfundur
  • Episode
      245
  • Published
      8 dec. 2020
  • Útgefandi
0 Umsagnir
0
Episode
245 of 1597
Lengd
45Mín.
Tungumál
enska
Gerð
Flokkur
Viðskiptabækur

Pfizer’s COVID-19 vaccinations are underway in the UK, while the FDA is expected to give U.S. approval this week. We’ll break down this monumental rollout.

Plus, Apple says its new fitness subscription service will launch next week, and unveils the new $549 Airpods Max. We’ll discuss Apple’s ‘flex’ in Rapid Fire.

And, Goldman Sachs raises its GDP outlook, as JPMorgan says any market correction is a buying opportunity. Is the market getting overly optimistic? We’ll debate.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


Hlustaðu og lestu

Stígðu inn í heim af óteljandi sögum

  • Lestu og hlustaðu eins mikið og þú vilt
  • Þúsundir titla
  • Getur sagt upp hvenær sem er
  • Engin skuldbinding
is Device Banner Block 894x1036
Cover for The FDA’s next move, $549 headphones and overly optimistic?

Other podcasts you might like ...